BamSEC and AlphaSense Join Forces
Learn More

Lyra Therapeutics Inc. – Indentures

OTC: LYRA    
Share price (7/17/26): $0.52    
Market cap (7/17/26): $923 thousand
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-1 21 pages Common Stock Purchase Warrant Lyra Therapeutics, Inc
12/34/56
EX-4.5
from S-1 18 pages Pre-Funded Common Stock Purchase Warrant Lyra Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 20 pages Common Stock Purchase Warrant Lyra Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Lyra Therapeutics, Inc
12/34/56
EX-4.8
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from S-3 52 pages Lyra Therapeutics, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.8
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 8-K 15 pages Lyra Therapeutics, Inc. Schedule of Holders of Warrants to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 13 pages This Warrant and the Shares of Common Stock Issued Upon Its Exercise Are Subject to the Restrictions on Transfer Set Forth in Section 5 of This Warrant
12/34/56
EX-4.1
from 8-K 5 pages Lyra Therapeutics, Inc. Amendment No. 1 to Ninth Amended and Restated Investor Rights Agreement
12/34/56
EX-4
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 10-Q 3 pages First Amendment to Lease
12/34/56
EX-4.2
from 10-Q 116 pages Waltham Woods Corporate Center 880 Winter Street Waltham, Massachusetts Lease Dated May 31, 2022
12/34/56
EX-4.2
from 8-K 13 pages Lyra Therapeutics, Inc. Schedule of Holders of Warrants to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 22 pages Lyra Therapeutics, Inc. Ninth Amended and Restated Investor Rights Agreement
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from S-3 51 pages Lyra Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from S-8 7 pages Restated Certificate of Incorporation of Lyra Therapeutics, Inc
12/34/56
EX-4.3
from S-1/A 12 pages Schedule of Holders of Warrants to Purchase Common Stock
12/34/56